Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Sees Significant Decline in Short Interest

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,100 shares, a decrease of 63.3% from the February 29th total of 3,000 shares. Based on an average daily volume of 19,000 shares, the days-to-cover ratio is presently 0.1 days.

Awakn Life Sciences Trading Down 8.1 %

OTCMKTS AWKNF opened at $0.09 on Thursday. Awakn Life Sciences has a twelve month low of $0.04 and a twelve month high of $0.36. The business’s 50-day moving average price is $0.10 and its 200 day moving average price is $0.12.

About Awakn Life Sciences

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.